TGFB1 and hepatocellular carcinoma: Additionally, activation of PI3K/AKT and TGF-β signaling contributed to the acquisition of miR-216a/217-induced sorafenib resistance in HCC; conversely, blocking these signals overcame sorafenib resistance and prevented metastases in HCC [229].